A study to determine humoral immunity to COVID-19 vaccine BNT162b2 in rheumatoid arthritis patients treated with Janus kinase inhibitors
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 07 Dec 2021 New trial record
- 25 Nov 2021 Results published in the Rheumatology